Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

SRx Health Solutions (SRXH) Debt to Equity (2016 - 2025)

SRx Health Solutions (SRXH) has disclosed Debt to Equity for 12 consecutive years, with $1.23 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Debt to Equity rose 309.83% year-over-year to $1.23, compared with a TTM value of $1.23 through Sep 2025, up 309.83%, and an annual FY2025 reading of $1.23, changed N/A over the prior year.
  • Debt to Equity was $1.23 for Q3 2025 at SRx Health Solutions, up from -$0.07 in the prior quarter.
  • Across five years, Debt to Equity topped out at $2.29 in Q4 2023 and bottomed at -$0.62 in Q1 2021.
  • Average Debt to Equity over 5 years is $0.35, with a median of $0.15 recorded in 2022.
  • The sharpest move saw Debt to Equity skyrocketed 468.26% in 2022, then crashed 290.64% in 2024.
  • Year by year, Debt to Equity stood at $0.09 in 2021, then surged by 468.26% to $0.53 in 2022, then skyrocketed by 330.3% to $2.29 in 2023, then tumbled by 101.66% to -$0.04 in 2024, then skyrocketed by 3340.31% to $1.23 in 2025.
  • Business Quant data shows Debt to Equity for SRXH at $1.23 in Q3 2025, -$0.07 in Q2 2025, and $0.15 in Q1 2025.